In a recent update, Citigroup analyst Patrick Donnelly has upgraded Hologic (HOLX, Financial) from a "Neutral" to a "Buy" rating. This change reflects increased confidence in the stock's potential performance in the near future.
The upgrade is accompanied by a significant adjustment in Hologic's (HOLX, Financial) price target. Citigroup has raised the price target for the stock from $60.00 to $80.00, indicating a 33.33% increase. The revised price target suggests optimism about Hologic's future prospects and financial health.
This adjustment comes amid ongoing market developments and is expected to influence investor sentiment positively, with the new price target set in USD. As of the latest report dated July 9, 2025, investors are encouraged to consider this updated evaluation when making strategic decisions regarding Hologic (HOLX, Financial).
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for Hologic Inc (HOLX, Financial) is $67.47 with a high estimate of $73.00 and a low estimate of $60.00. The average target implies an upside of 3.97% from the current price of $64.90. More detailed estimate data can be found on the Hologic Inc (HOLX) Forecast page.
Based on the consensus recommendation from 22 brokerage firms, Hologic Inc's (HOLX, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Hologic Inc (HOLX, Financial) in one year is $83.17, suggesting a upside of 28.15% from the current price of $64.9. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Hologic Inc (HOLX) Summary page.
